Sunvozertinib Tablets (brand name: Sunvozera) is a prescription drug that can only be purchased and used under the guidance of a licensed pharmacist with a doctor’s prescription. Based on the latest available information, the drug is obtainable through the following channels:
Formal medical institutions in mainland China: Sunvozertinib Tablets has been launched for sale in selected hospitals and pharmacies across mainland China. For example, Shenzhen United Family Xinfeng Hospital and other medical institutions have introduced the drug and provide it at a cost-price without markup for patients.
Licensed online pharmaceutical platforms: The drug is also available for purchase on certain qualified online pharmaceutical platforms in China, with slight price variations across different platforms and regions.
Important Notes
Sunvozertinib Tablets is a prescription-only medication; a formal prescription issued by a physician after a comprehensive assessment of the patient’s condition is a mandatory prerequisite for purchase.
This drug is indicated for patients with non-small cell lung cancer (NSCLC) harboring specific genetic mutations (EGFR exon 20 insertion mutations), and confirmation of the eligible indication through genetic testing is required prior to administration.
Do not purchase the drug through unauthorized channels to avoid counterfeit products and potential safety hazards. It is recommended to prioritize hospital pharmacies or nationally certified online pharmaceutical platforms for purchase.
